Navigation Links
Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis
Date:10/15/2007

erse reactions are cytopenias, infusion reactions, and immunosuppression/infections.

About Genzyme

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 9,500 employees in locations spanning the globe and 2006 revenues of $3.2 billion. In 2007, Genzyme was chosen to receive the National Medal of Technology, the highest honor awarded by the President of the United States for technological innovation. In 2006 and 2007, Genzyme was selected by FORTUNE as one of the "100 Best Companies to Work for" in the United States.

With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.

Genzyme Hosts Investor Call This Morning

Genzyme will host an investor call with Professor Alastair Compston this morning, Monday, October 15, from 8:30-9:30 a.m. EST. Three-year, top-line data from the Phase 2 study will be presented and there will be opportunity for investors to ask questions of the alemtuzumab investigator.

To participate in the call, please dial 1-888-889-4416 in the U.S. or 1-773-756-0616 outside of the U.S. The participant passcode is "Genzyme."

A replay of this call will be available by dialing 203-369-3276. This call will also be available live on the investor events section of http://www.genzyme.com. Replays
'/>"/>

SOURCE Genzyme Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
2. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
3. Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line Results with ...
4. Evotec Reports Positive Proof-of-Concept Top-Line Results with Insomnia Drug Candidate EVT 201
5. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
6. Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Companys Investigational Drug to Treat Cocaine and Methamphetamine Addiction
7. Cobalis Expects to Report Phase III Top-Line Results in May
8. XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
9. Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntingtons Disease
10. UCB Announces Positive Top-Line Phase III Results for Keppra as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
11. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with Tovaxin for Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... CHAPEL HILL, N.C. , Sept. 4, 2015 ... Science Liaisons (MSLs) and other Field-Based Medical Specialists ... physicians, key opinion leaders, and thought leaders in ... the effectiveness of their field-based teams, companies are ... in order to align countries with corporate objectives ...
(Date:9/4/2015)... 4, 2015  Essilor is pleased to announce the ... against the eyestrain that comes with the constant connection ... as an everyday pair of glasses to provide comfort ... on smart phones, tablets and computers for hours at ... require a prescription but also those who currently wear ...
(Date:9/4/2015)... 2015  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... Wells Fargo Securities 2015 Healthcare Conference in Boston ... th at 2:30 p.m. Eastern Time. To listen to ... visit the Investors section of the Company,s Web site at ... days after the event.  Orexigen Contact: , ...
Breaking Medicine Technology:New Study Presents Tactics and Insights on How to Effectively Globalize Medical Science Liaison Programs in the Pharmaceutical Industry 2Essilor Launches New Eyezen Glasses Specifically Designed For A Digital Focused Audience 2
... July 21, 2011 BioMedix™, a leader in providing ... been awarded a U.S. Patent recognizing its innovative solutions ... On July 19, 2011, the United States ... entitled "System and Method for Testing for Cardiovascular Disease," ...
... IRVINE, Calif., July 21, 2011 Endologix, Inc. (NASDAQ: ... aortic disorders, today announced financial results for the three and ... Endologix President and Chief Executive Officer, said, "We are pleased ... to achieve our growth and new product development goals for ...
Cached Medicine Technology:BioMedix™ Receives Patent for Its Innovative Collaborative Care Business Method 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 3Endologix Reports 22% Second Quarter 2011 Revenue Growth 4Endologix Reports 22% Second Quarter 2011 Revenue Growth 5Endologix Reports 22% Second Quarter 2011 Revenue Growth 6Endologix Reports 22% Second Quarter 2011 Revenue Growth 7Endologix Reports 22% Second Quarter 2011 Revenue Growth 8Endologix Reports 22% Second Quarter 2011 Revenue Growth 9
(Date:9/4/2015)... ... 2015 , ... According to an article published August 4th by ... data showing that it is safe for pregnant women to undergo local anesthesia needed ... local anesthesia with a group that hadn’t, researchers were able to determine that “local ...
(Date:9/4/2015)... California (PRWEB) , ... September 04, 2015 , ... The ... behalf of Tanya De La Paz. , Schmidt National Law Group, a leading ... Northern District of California against Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates ...
(Date:9/4/2015)... GA (PRWEB) , ... September 04, 2015 , ... After ... is in desperate need of new apparel. In an effort to assist the team, ... Marietta, has launched a charity drive to raise funds for the new uniforms. , ...
(Date:9/4/2015)... ... September 04, 2015 , ... Keeping mold top of ... the home is quite common. Mold can grow anywhere - on carpet, clothing, food, ... Checking for excessive moisture and water in the home is key to preventing mold ...
(Date:9/4/2015)... ... ... are looking for a quick and convenient way to produce a hot remedy for colds. ... a quick and simple way to brew a hot cup of cold remedy when desired. ... they enhance comfort and health. The invention features a novel design that is lightweight, compact ...
Breaking Medicine News(10 mins):Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2
... strike of Maharastra Doctors. The healthcare services continues to ... instances.// The government today took a firm stand and ... ,Currently with this decision over 350 doctors ... doctors from 15 government-managed hospitals have stayed away from ...
... detection of the H5N1 viral strain in a wild goose ... flu infection to the sixth German state has been confirmed//. ... and is at significant risk of a dangerous epidemic. ... kilometres of where the bird was found as tests were ...
... the Duke University Medical Center have found that taking ... the chances of dying.// It was found that there ... patients who took such medications in spite of being ... degree of heart disease and severity of depression were ...
... involve a weakening of the muscles or ligaments that ... pelvic-floor disorders many of the activities are restricted. //In ... in severe cases, they may actually protrude outside the ... mild cases and surgery for more severe cases. It ...
... winter depression, of which 8 to 10 million are ... ,Current research indicates that the absence of sunlight ... as loss of energy, fatigue, lethargy, decreased activity, sadness, ... "winter depression" who go untreated can lose their jobs, ...
... College of Georgia said that genes that control blood pressure ... on more than 500 pairs of black and // white ... that changes in gene expression between ages 14 and 18 ... variation that occurred by age 18. The results were presented ...
Cached Medicine News:Health News:More Doctors Suspended As Strike Enters Seventh Day 2Health News:Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed 2Health News:'Winter Blues' Treated by Breakthrough Lighting Technology 2Health News:Genetic Reasons behind Change in One’s Blood Pressur 2
... designed for vascular labs already equipped ... Its primary use will be for ... cuff with air. Blood pressures ... - a proximal occluding cuff connected ...
... System is perfect for larger surgery suites that ... anesthetic agent. , ,The Integra II SP ... stance, has a larger work area. The ... in both the Integra I and II. ...
... Closures represent a needleless, intuitive ... of surgical incisions, excisions and ... film design provides unparalleled improvements ... visibility and cosmetic results, translating ...
The Next Generation in Operating Room Equipment and Management Solutions is here Today. NuBoom is a self-contained, pedestal-mounted boom that houses medical, audio and visual equipment....
Medicine Products: